Are you Dr. Cragg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1000 4th St Sw
Suite Cc
Mason City, IA 50401Phone+1 641-422-6300Fax+1 641-422-6294
Summary
- Dr. Louise Cragg, MD is an oncologist in Mason City, Iowa. She is currently licensed to practice medicine in Iowa and Virginia. She is affiliated with MercyOne North Iowa Medical Center.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1993 - 1996
McGill University Faculty of MedicineClass of 1990
Certifications & Licensure
IA State Medical License 2002 - 2022
VA State Medical License 1998 - 2004
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Publications & Presentations
PubMed
- 34 citationsPhase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) LymphomaJohn D. Roberts, Mitchell R. Smith, Eric J. Feldman, Louise Cragg, Michael Millenson
Clinical Cancer Research. 2006-10-01 - 20 citationsPhase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.Louise Cragg, Michael Andreeff, Eric J. Feldman, John D. Roberts, Anthony J. Murgo
Clinical Cancer Research. 2002-07-01 - 7 citationsPhase I Study of Bryostatin-1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin's LymphomaJohn D. Roberts, Mitchell R. Smith, Eric J. Feldman, Louise Cragg, Steven Grant
Clinical Lymphoma. 2002-12-01
